Company Dishman Carbogen Amcis Limited

Equities

DCAL

INE385W01011

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:47 2024-05-03 am EDT 5-day change 1st Jan Change
228.6 INR -0.67% Intraday chart for Dishman Carbogen Amcis Limited -0.46% +33.72%

Business Summary

Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Company’s segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.

Number of employees: 1,295

Sales per Business

INR in Million2022Weight2023Weight Delta
Contract Research and Manufacturing Services
80.6 %
16,493 77.0 % 19,453 80.6 % +17.95%
Marketable Molecules (including Others)
19.4 %
4,914 23.0 % 4,676 19.4 % -4.83%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
367 1.7 % 24,129 100.0 % +6,483.68%

Managers

Managers TitleAgeSince
Chief Executive Officer 38 12-04-06
Director of Finance/CFO 42 -
Chief Operating Officer - -
Compliance Officer 37 17-03-16
General Counsel - -
Corporate Officer/Principal - -
Corporate Officer/Principal 63 -
Human Resources Officer - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chairman 73 07-03-16
Director/Board Member 73 17-03-16
Director/Board Member 76 17-03-16
Chief Executive Officer 38 12-04-06
Director/Board Member 70 17-03-16
Director/Board Member 42 19-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 156,783,095 46,925,444 ( 29.93 %) 0 29.93 %

Shareholders

NameEquities%Valuation
Adimans Technologies LLP
59.32 %
93,002,442 59.32 % 263 M ₹
8,200,000 5.230 % 23 M ₹
HBM Partners AG (Investment Management)
3.546 %
5,560,116 3.546 % 16 M ₹
Massachusetts Institute of Technology Foundation
1.952 %
3,060,000 1.952 % 9 M ₹
L&T Investment Management Ltd.
1.516 %
2,377,050 1.516 % 7 M ₹
quant Money Managers Ltd.
1.163 %
1,823,000 1.163 % 5 M ₹
HSBC Asset Management (India) Pvt Ltd.
0.9414 %
1,476,000 0.9414 % 4 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.2926 %
458,788 0.2926 % 1 M ₹
Tata Asset Management Ltd.
0.1131 %
177,320 0.1131 % 500 904 ₹
Franklin Templeton Asset Management (India) Pvt Ltd.
0.1021 %
160,000 0.1021 % 451 978 ₹

Company contact information

Dishman Carbogen Amcis Ltd.

Dishman Corporate House Opp. Jayantilal Park BRTS

380058, Ahmedabad

+91 27 1742 0102

http://imdcal.com
address Dishman Carbogen Amcis Limited(DCAL)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Other
  1. Stock Market
  2. Equities
  3. DCAL Stock
  4. Company Dishman Carbogen Amcis Limited